After the successful launch of Nemera’s next generation nasal spray pump within its Crimp-on version, Advancia® Snap-on version is now on the South Korean market with an intranasal decongestant nasal spray.
JW Pharmaceutical has recently launched their decongestant range under 2 formats with Advancia® Snap-on: Adults and Kids.
With its key differentiating features, Nemera is happy to support customer launches with “made-in-France” Advancia®.

Advancia® embodies a major breakthrough in nasal drug delivery by providing patients with a user-friendly package and a convenient anti-clogging technology:

  • The thinner actuator extremity was designed to suit perfectly use in both children and adults.
  • The protective overcap is more hygienic and allows transportation within a bag or pocket, preventing from any accidental actuation.
  • With its user-independence and anti-clogging technical features, patients are guaranteed to have their full dose delivered, no matter how they use their nasal spray.

This user-independent device delivers an excellent dose consistency,
exceeding the most stringent regulatory requirements. Moreover, with its anticlogging
technology, the system ensures spray delivery even with formulations
that tend to crystallize. The extended prime retention, up to several months,
offers a unique solution for onandoff treatments; the patients do not have to reprime
the pump to ensure full delivery of the dose after multiple weeks of
nonuse. All these features improve patient compliance.